Grace Therapeutics, Inc. Payments to Acquire Short-term Investments
Grace Therapeutics, Inc. (GRCE) reported Payments to Acquire Short-term Investments of $0 for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-18.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2026-06-18
- Grace Therapeutics, Inc. payments to acquire short-term investments for the quarter ending 2026-03-31 was $0.00.
- Grace Therapeutics, Inc. payments to acquire short-term investments for the quarter ending 2025-12-31 was $0.00.
- Grace Therapeutics, Inc. payments to acquire short-term investments for the quarter ending 2025-09-30 was $0.00.
- Grace Therapeutics, Inc. payments to acquire short-term investments for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Grace Therapeutics, Inc. payments to acquire short-term investments for fiscal 2026 was $0.00, a 100.00% decline from fiscal 2025.
- Grace Therapeutics, Inc. payments to acquire short-term investments for fiscal 2025 was $15.00K, a 99.77% decline from fiscal 2024.
- Grace Therapeutics, Inc. payments to acquire short-term investments for fiscal 2024 was $6.55M, a 30.69% increase from fiscal 2023.
- Grace Therapeutics, Inc. payments to acquire short-term investments for fiscal 2023 was $5.01M, a 85.64% decline from fiscal 2022.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $0.00 derived: sum of 2 quarters · filed 2026-06-18 | $0.00 derived: sum of 3 quarters · filed 2026-06-18 | $0.00 10-K · filed 2026-06-18 |
| 2025-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | $0.00 derived: sum of 2 quarters · filed 2026-02-12 | $0.00 10-Q · filed 2026-02-12 | $0.00 derived: sum of 4 quarters · filed 2026-06-18 |
| 2025-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 3 quarters · filed 2026-06-18 | $0.00 derived: sum of 4 quarters · filed 2026-06-18 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-12 | $0.00 derived: sum of 2 quarters · filed 2026-06-18 | $0.00 derived: sum of 3 quarters · filed 2026-06-18 | $0.00 derived: sum of 4 quarters · filed 2026-06-18 |
| 2025-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $0.00 derived: sum of 2 quarters · filed 2026-06-18 | $0.00 derived: sum of 3 quarters · filed 2026-06-18 | $15.00K 10-K · filed 2026-06-18 |
| 2024-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | $0.00 derived: sum of 2 quarters · filed 2026-02-12 | $15.00K 10-Q · filed 2026-02-12 | $15.00K derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13 | $15.00K 10-Q · filed 2025-11-13 | $15.00K derived: sum of 3 quarters · filed 2025-11-13 | $6.57M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $15.00K 10-Q · filed 2025-08-12 | $15.00K derived: sum of 2 quarters · filed 2025-08-12 | $6.57M derived: sum of 3 quarters · filed 2025-08-12 | $6.57M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-23 | $6.55M derived: sum of 2 quarters · filed 2025-06-23 | $6.55M derived: sum of 3 quarters · filed 2025-06-23 | $6.55M 10-K · filed 2025-06-23 |
| 2023-12-31 | $6.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | $6.55M derived: sum of 2 quarters · filed 2025-02-13 | $6.55M 10-Q · filed 2025-02-13 | $6.55M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | $0.00 derived: sum of 3 quarters · filed 2024-11-13 | $5.00M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-09 | $0.00 derived: sum of 2 quarters · filed 2024-08-09 | $5.00M derived: sum of 3 quarters · filed 2024-08-09 | $5.00M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-21 | $5.00M derived: sum of 2 quarters · filed 2024-06-21 | $5.00M derived: sum of 3 quarters · filed 2024-06-21 | $5.01M 10-K · filed 2024-06-21 |
| 2022-12-31 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-12 | $5.00M derived: sum of 2 quarters · filed 2024-02-12 | $5.01M 10-Q · filed 2024-02-12 | $5.09M derived: sum of 4 quarters · filed 2024-02-12 |
| 2022-09-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13 | $14.00K 10-Q · filed 2023-11-13 | $91.00K derived: sum of 3 quarters · filed 2023-11-13 | $13.41M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $16.00K 10-Q · filed 2023-08-11 | $93.00K derived: sum of 2 quarters · filed 2023-08-11 | $13.42M derived: sum of 3 quarters · filed 2023-08-11 | $26.64M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-23 | $13.40M derived: sum of 2 quarters · filed 2023-06-23 | $26.63M derived: sum of 3 quarters · filed 2023-06-23 | $34.93M 10-K · filed 2023-06-23 |
| 2021-12-31 | $13.32M 10-Q · filed 2022-02-14 | $26.55M derived: sum of 2 quarters · filed 2022-02-14 | $34.85M 10-Q · filed 2023-02-14 | $43.27M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-09-30 | $13.23M 10-Q · filed 2021-11-10 | $21.53M 10-Q · filed 2022-11-14 | $29.95M derived: sum of 3 quarters · filed 2022-08-11 | $31.32M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-06-30 | $8.30M 10-Q · filed 2022-08-11 | $16.72M derived: sum of 2 quarters · filed 2022-08-11 | $18.09M derived: sum of 3 quarters · filed 2022-08-11 | $18.11M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $8.42M derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-21 | $9.79M derived: sum of 2 quarters · filed 2022-06-21 | $9.81M derived: sum of 3 quarters · filed 2022-06-21 | $9.81M 10-K · filed 2022-06-21 |
| 2020-12-31 | $1.37M 10-Q · filed 2022-02-14 | $1.39M derived: sum of 2 quarters · filed 2022-02-14 | $1.39M 10-Q · filed 2022-02-14 | $3.32M derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-09-30 | $21.00K 10-Q · filed 2021-11-10 | $21.00K 10-Q · filed 2021-11-10 | $1.94M derived: sum of 3 quarters · filed 2021-11-10 | $1.98M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 | $1.92M derived: sum of 2 quarters · filed 2021-08-12 | $1.96M derived: sum of 3 quarters · filed 2021-08-12 | $1.97M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $1.92M 10-K · filed 2020-06-29 | $1.96M derived: sum of 2 quarters · filed 2021-02-09 | $1.97M derived: sum of 3 quarters · filed 2021-02-09 | $1.92M 10-K · filed 2021-06-22 |
| 2019-12-31 | $32.00K 10-Q · filed 2021-02-09 | $43.00K derived: sum of 2 quarters · filed 2021-02-09 | $2.06M 10-Q · filed 2021-02-09 | $20.91M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-09-30 | $11.00K 10-Q · filed 2020-11-16 | $2.03M 10-Q · filed 2020-11-16 | $20.88M derived: sum of 3 quarters · filed 2020-11-16 | |
| 2019-06-30 | $2.02M 10-Q · filed 2020-08-13 | $20.87M derived: sum of 2 quarters · filed 2020-08-13 | ||
| 2019-03-31 | $18.85M 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |